Studies have identified NGAL concentrations in serum and urine as independent predictors of CKD progression [138] in patients with moderate renal disease, and it has been noted that its urinary concentrations may predict the development of CKD in obese adolescents with normal or reduced GFR [139]. The gene discussed is LCN2; the disease is chronic kidney disease.